Rb Hlth Drug Patent Portfolio
Rb Hlth owns 4 orange book drugs protected by 4 US patents Given below is the list of Rb Hlth's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6372252 | Guaifenesin sustained release formulation and tablets | 28 Apr, 2020 | Expired |
| US6955821 | Sustained release formulations of guaifenesin and additional drug ingredients | 28 Apr, 2020 | Expired |
| US7838032 | Sustained release of guaifenesin | 28 Apr, 2020 | Expired |
| US5980882 | Drug-resin complexes stabilized by chelating agents | 16 Apr, 2017 | Expired |
Latest Legal Activities on Rb Hlth's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Rb Hlth.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 26 Dec, 2022 | US7838032 (Litigated) |
|
Expire Patent
Critical
| 26 Dec, 2022 | US7838032 (Litigated) |
|
Expire Patent
Critical
| 26 Dec, 2022 | US7838032 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 11 Jul, 2022 | US7838032 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 11 Jul, 2022 | US7838032 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 11 Jul, 2022 | US7838032 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 10 May, 2018 | US7838032 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 10 May, 2018 | US7838032 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 10 May, 2018 | US7838032 (Litigated) |
|
Patent Issue Date Used in PTA Calculation
Critical
| 23 Nov, 2010 | US7838032 (Litigated) |
|
Patent Issue Date Used in PTA Calculation
Critical
| 23 Nov, 2010 | US7838032 (Litigated) |
|
Patent Issue Date Used in PTA Calculation
Critical
| 23 Nov, 2010 | US7838032 (Litigated) |
|
Recordation of Patent Grant Mailed
Critical
| 23 Nov, 2010 | US7838032 (Litigated) |
|
Recordation of Patent Grant Mailed
Critical
| 23 Nov, 2010 | US7838032 (Litigated) |
|
Recordation of Patent Grant Mailed
Critical
| 23 Nov, 2010 | US7838032 (Litigated) |
Rb Hlth's Family Patents
Rb Hlth Drug List
Given below is the complete list of Rb Hlth's drugs and the patents protecting them.
1. Delsym
Delsym is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5980882 | Drug-resin complexes stabilized by chelating agents |
16 Apr, 2017
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Delsym's drug page
2. Mucinex
Mucinex is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6372252 | Guaifenesin sustained release formulation and tablets |
28 Apr, 2020
(4 years ago)
| Expired |
| US6955821 | Sustained release formulations of guaifenesin and additional drug ingredients |
28 Apr, 2020
(4 years ago)
| Expired |
| US7838032 | Sustained release of guaifenesin |
28 Apr, 2020
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Mucinex's drug page
3. Mucinex D
Mucinex D is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6372252 | Guaifenesin sustained release formulation and tablets |
28 Apr, 2020
(4 years ago)
| Expired |
| US6955821 | Sustained release formulations of guaifenesin and additional drug ingredients |
28 Apr, 2020
(4 years ago)
| Expired |
| US7838032 | Sustained release of guaifenesin |
28 Apr, 2020
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Mucinex D's drug page
4. Mucinex Dm
Mucinex Dm is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6372252 | Guaifenesin sustained release formulation and tablets |
28 Apr, 2020
(4 years ago)
| Expired |
| US6955821 | Sustained release formulations of guaifenesin and additional drug ingredients |
28 Apr, 2020
(4 years ago)
| Expired |
| US7838032 | Sustained release of guaifenesin |
28 Apr, 2020
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Mucinex Dm's drug page